Daily as of 3 Nov 16:00 ET
- Price
- between the two $8.87 vs 50 $11.91 / 200 $8.62
- Projection
- 💀Death cross estimated in 20 to 30 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 20 Mar 2025 · projected 28 bars out · tested 5 bars
SLS | SELLAS Life Sciences GroupNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$8.87
+$0.32 (+3.74%)
SELLAS Life Sciences Group (SLS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
Right now the daily is the chart to watch. The 50 SMA sits above the 200, but the two have been closing on each other and a death cross is projected within 30 bars. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $9.68 vs 50 $7.53 / 200 $2.97
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 19 Jan 2026 · projected 19 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $8.83 vs 50 $11.19 / 200 $11.85
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 16 Oct 2026 bar 2 · projected 20 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Oct 2026 | 💀Death | 4-hour | 20 bars out | 2 bar cross test |
| week of 19 Jan 2026 | 🟨Golden moderate | weekly | 19 bars out | Not tested |
| 22 Dec 2025 | 🟨Golden | 4-hour | 23 bars out | Not tested |
| 18 Nov 2025 | 💀Death | 4-hour | 23 bars out | Not tested |
| 15 Oct 2025 | 🟨Golden | 4-hour | 22 bars out | Not tested |
About SLS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$66.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmid